Agricultural and Veterinary Chemicals Instrument No. 1 (Manufacturing Principles) 2007 (Cth)
Agricultural and Veterinary Chemicals
Instrument No. 1
(Manufacturing Principles)
2007
I, Roland Joseph Smith, Chief Executive Officer of the Australian Pesticides and Veterinary Medicines Authority, acting in accordance with my powers under subsection 32(1) of the Agricultural and Veterinary Chemicals (Administration) Act 1992, make this Instrument for the purposes of subsection 23(1) of the Agricultural and Veterinary Chemicals Act 1994.
RJ Smith
Chief Executive Officer
Dated this second day of April 2007
1. Name of Instrument
This Instrument is the Agricultural and Veterinary Chemicals Instrument No. 1 (Manufacturing Principles) 2007.
2. Commencement
This Instrument commences on 1 May 2007.
3. Determination of Manufacturing Principles
Pursuant to subsection 23(1) of the Agricultural and Veterinary Chemicals Act 1994 it is determined that, for the purposes of Part 8 of the Agricultural and Veterinary Chemicals Code scheduled to the Agricultural and Veterinary Chemicals Code Act 1994, the written principles to be observed in the manufacture of veterinary chemical products are as prescribed in the Schedule to this Instrument.
Schedule—Manufacturing Principles for
Veterinary Chemical Products
1. Interpretation
(1) Unless the contrary intention appears expressions used in the Agvet Code or the Agvet Regulations and in these Principles have the same meaning in these Principles as in the Agvet Code or the Agvet Regulations.
(2) In these Principles, unless the contrary intention appears:
Code of Good Manufacturing Practice means the Australian Code of Good Manufacturing Practice for Veterinary Chemical Products (including its Annexes) published by the Australian Pesticides and Veterinary Medicines Authority on 29 March 2007;
the Actmeans the Agricultural and Veterinary Chemicals Act 1994;
specified biological process means a process of manufacture of a veterinary chemical product involving one or more of the following:
(a) microbial, cell or tissue culture, including fermentation;
(b) extraction from biological tissues, including animal and plant tissues;
(c) derivatives from blood and body fluids;
(d) genetic manipulation, including recombinant DNA and hybridoma techniques;
(e) biotechnological processes;
(f) propagation in embryos or animals;
(g) formation or isolation of protein fragments or their derivatives.
manufacture in relation to a chemical product means:
(a) to produce the chemical product; or
(b) to engage in any part of the process of producing the chemical product or of bringing the chemical product to its final state, including engaging in the processing, assembling, packaging, labelling, storage, sterilising, testing or releasing from manufacture of the chemical product or of any component or ingredient of the chemical product as part of that process.
2. Compliance with Code of Good Manufacturing Practice
Subject to these Principles, veterinary chemical products must be manufactured in compliance with the Australian Pesticides and Veterinary Medicines Authority’s Australian Code of Good Manufacturing Practice for Veterinary Chemical Products as in force on 29 March 2007.
3. Quality management
(1) Manufacturers of veterinary chemical products must have in place a quality assurance system to ensure that finished products are fit for their intended use, comply with registration requirements and do not place treated animals or users at risk due to inadequate quality, safety or efficacy.
(2) The quality assurance system must ensure that:
(a) appropriate procedures are in place to ensure that relevant quality standards are met;
(b) all materials involved in the manufacturing process comply with required quality standards before they are released for use in manufacture;
(c) there are measures designed to prevent cross-contamination;
(d) there are safeguards and controls in place designed to prevent the occurrence of foreseeable errors or process failures; and
(e) finished products have been made and stored correctly, and comply with required quality standards before they are released for supply.
(3) The quality assurance system must be relevant to the nature and intended use of the product. It must be fully documented, monitored for effectiveness and provide for continuous improvement.
4. Personnel and training
(1) Veterinary chemical products must be manufactured under the management and supervision of appropriately qualified, trained or experienced persons who:
(a) understand the specialised technical, quality and legal requirements relating to the manufacture of veterinary chemical products for which they have responsibility; and
(b) have their duties and responsibilities clearly defined by the manufacturer.
(2) Manufacturing staff must be trained to a satisfactory level of competency in:
(a) the basic principles of good manufacturing practice; and
(b) the specific duties, in connection with the manufacture of veterinary chemical products, that they are required to perform.
(3) There must be a sufficient number of competent personnel to carry out all required tasks.
5. Buildings and grounds
(1) Veterinary chemical products must be manufactured in buildings that are located, designed, constructed, maintained and utilised to:
(a) suit the operations carried out in them;
(b) ensure protection of the veterinary chemical products from contamination;
(c) permit effective cleaning and maintenance, including cleaning after processes have been completed; and
(d) minimise the risk of manufacturing error.
(2) The products must also be manufactured in an environment, or in equipment fitted with precautionary measures, that:
(a) ensures a standard of hygiene appropriate to the class of veterinary chemical product being manufactured;
(b) minimises the risk of cross-contamination of the finished product, or of materials or components that are used or manufactured at the premises; and
(c) ensures the safety of operators and protect the outside environment.
6. Equipment
(1) Equipment used in the manufacture of veterinary chemical products must be suitable for its intended purpose and appropriately operated, maintained and cleaned. Equipment must be correctly installed and operated in accordance with written instructions that are appropriate for the equipment.
(2) The design and layout of equipment must be such that:
(a) the risk of manufacturing error is minimised; and
(b) effective cleaning and maintenance are possible, in order to avoid cross-contamination of either intermediate materials or the finished product, the buildup of dust or dirt and, in general, to avoid any adverse environmental effect on the quality of the product.
7. Documentation
Manufacturers of veterinary chemical products must establish and maintain a system of documentation, document control and record keeping that:
(a) provides precise specifications for starting materials, intermediate materials and finished products, manufacturing formulae and instructions, and operating procedures for associated manufacturing and quality control activities;
(b) provides a complete history of each item, batch, or quantity manufactured in a specified timeframe, of veterinary chemical product produced at the premises; and
(c) establishes a traceable connection between raw materials and the finished product.
8. Computer systems
(1) Where, in any step of manufacture, a computer is used for any activity that may affect the quality, safety or efficacy of a product, then the computer system must be subject to the principles of quality system management to ensure operational suitability.
(2) The introduction of computer systems into any manufacturing process, including materials control, processing control, quality control and product distribution, must not adversely affect product quality or quality assurance.
9. Production
(1) Veterinary chemical products must be manufactured to specifications in accordance with manufacturing information supplied as part of their application for registration including any subsequent approved variations.
(2) Production operations must follow documented procedures that have been clearly defined by the manufacturer.
(3) Any critical manufacturing process and any change to that manufacturing process, must be validated and formally approved by an authorised person. Where a change in the manufacturing process affects the registered specifications of the finished product, formal approval of such changes must be obtained from the registering authority before the affected product is released for supply.
10. Quality control
(1) Manufacturers of veterinary chemical products must have in place an effective quality control system that is designed to ensure that, before products are released from manufacture for supply, they meet registered specifications and have been manufactured in accordance with the manufacturer’s documented procedures.
(2) The person responsible for quality control must be sufficiently independent of other aspects of the manufacturing operation to allow effective implementation of the quality control function.
(3) Manufacturers must ensure that analytical laboratories and animal testing facilities used in a step of manufacture follow the principles of good laboratory practice.
11. Contract manufacture
(1) Where all or part of the manufacture of a veterinary chemical product is contracted to another party, the licensed manufacturer must ensure that, before manufacture commences, all parties have signed a written ‘GMP Agreement’ that clearly specifies each party’s responsibility in relation to every aspect of the manufacturing process, assurance of product quality and consistency with product registration particulars.
(2) Arrangements for contracted steps of manufacture must not compromise the quality of the product.
Where a contractor is authorised to manufacture under the licence of another manufacturer, the licence holder must exert direct control and oversight of the quality management of the contracted step.
12. Internal audits
Manufacturers of veterinary chemical products must regularly and systematically carry out internal audits of all aspects of their manufacturing operations, as well as of their quality assurance program, in order to monitor compliance with their authorised procedures, standards and requirements and to ensure product quality. Steps must be taken to implement any necessary corrective and preventive action identified by those internal audits and to assess the outcomes.
13. Complaints and product recalls
(1) Manufacturers of veterinary chemical products must have in place a system of handling complaints regarding products they have manufactured or otherwise handled on the licensed premises. There must be a documented system of recording, investigating and, where appropriate, acting upon all complaints that may be related to product quality.
(2) Manufacturers must also have in place a documented and effective procedure for recalling from the marketplace product that is known to be defective, or is suspected of being defective.
14. Sterile products
Veterinary chemical products that are required to be, or are represented as being, sterile, must be manufactured:
(a) in separate, controlled areas in the premises that have:
high standards of hygiene; and
(ii) a system of controlling particulate contaminants that is appropriate to the class of veterinary chemical product being manufactured;
(b) with special care and attention to detail; and
(c) in accordance with procedures established and validated by the manufacturer.
The manufacturer must establish procedures and have equipment available (or in the case of bioburden, have access to equipment) to adequately monitor:
(a) the microbiological status of the environment in production areas; and
(b) the microbiological burden of the veterinary chemical products that are to be sterilised.
15. Immunobiologicals and other products of biological origin
Veterinary immunobiological products and other chemical products of biological origin, including those that are manufactured using a specified biological process, must be manufactured:
(a) using biological starting materials that are, or are derived from, biological materials demonstrated to be as free as practicable from adventitious contamination;
(b) in premises designed, constructed and maintained so as to provide an appropriate level of containment of the biological or microbiological agents being handled and to permit effective decontamination from these agents or from toxic residues by procedures that:
(i) are established and validated by the manufacturer; and
(ii) maintain the safety of personnel; and
(c) in cases where uniformity of product depends on deriving batches from a seed lot:
(i) by maintaining the lots in secure and protective storage; and
(ii) by keeping meticulous records of their origin and disposition.
0
0
0